- Home
- NCMI vs LENZ Comparison
NCMI vs LENZ Comparison
Compare NCMI & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCMI
- LENZ
- Stock Information
- Founded
- NCMI 2005
- LENZ 2019
- Country
- NCMI United States
- LENZ United States
- Employees
- NCMI N/A
- LENZ N/A
- Industry
- NCMI Advertising
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- NCMI Consumer Discretionary
- LENZ Health Care
- Exchange
- NCMI Nasdaq
- LENZ Nasdaq
- Market Cap
- NCMI 653.0M
- LENZ 614.9M
- IPO Year
- NCMI 2007
- LENZ 2021
- Fundamental
- Price
- NCMI $6.70
- LENZ $23.82
- Analyst Decision
- NCMI Strong Buy
- LENZ Strong Buy
- Analyst Count
- NCMI 4
- LENZ 6
- Target Price
- NCMI $7.56
- LENZ $35.40
- AVG Volume (30 Days)
- NCMI 586.9K
- LENZ 197.6K
- Earning Date
- NCMI 03-17-2025
- LENZ 11-06-2024
- Dividend Yield
- NCMI N/A
- LENZ 30.67%
- EPS Growth
- NCMI N/A
- LENZ N/A
- EPS
- NCMI N/A
- LENZ N/A
- Revenue
- NCMI $245,300,000.00
- LENZ N/A
- Revenue This Year
- NCMI $47.09
- LENZ N/A
- Revenue Next Year
- NCMI $19.46
- LENZ N/A
- P/E Ratio
- NCMI N/A
- LENZ N/A
- Revenue Growth
- NCMI 47.68
- LENZ N/A
- 52 Week Low
- NCMI $3.66
- LENZ $2.57
- 52 Week High
- NCMI $7.60
- LENZ $38.93
- Technical
- Relative Strength Index (RSI)
- NCMI 53.32
- LENZ 35.08
- Support Level
- NCMI $5.93
- LENZ $21.34
- Resistance Level
- NCMI $6.86
- LENZ $23.84
- Average True Range (ATR)
- NCMI 0.27
- LENZ 1.58
- MACD
- NCMI 0.04
- LENZ -0.39
- Stochastic Oscillator
- NCMI 71.96
- LENZ 25.78
About NCMI National CineMedia Inc.
National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.
About LENZ LENZ Therapeutics Inc. Common Stock
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.